Julie Sanderson

Dr. Julie Sanderson


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1999 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
JSJulie Sanderson
Julie Sanderson
WMW.Russell McLauchlan
W.Russell McLauchlan
GWGary Williamson
Gary Williamson

1 February 2016 in Experimental Eye Research
Verified
Journal Article
Closed access
AOAndrew Osborne
Andrew Osborne
MHMarina Hopes
Marina Hopes
PWPhillip Wright
Phillip Wright
DBDavid C. Broadway
David C. Broadway
JSJulie Sanderson
Julie Sanderson

26 January 1996 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JSJulie Sanderson
Julie Sanderson
JMJ.M. Marcantonio
J.M. Marcantonio
GDG. Duncan
G. Duncan


30 January 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AOAndrew Osborne
Andrew Osborne
AAAmal Qassim Aldarwesh
Amal Qassim Aldarwesh
JRJeremy D Rhodes
Jeremy D Rhodes
DBDavid C Broadway
David C Broadway
CEClaire Everitt
Claire Everitt
JSJulie Sanderson
Julie Sanderson
Elevated intraocular pressure (IOP) is a major risk factor for glaucoma. One consequence of raised IOP is that ocular tissues are subjected to increased hydrostatic pressure (HP). The effect of raised HP on stress pathway signaling and retinal ganglion cell (RGC) survival in the human retina was investigated. A chamber was designed to expose cells to increased HP (constant and fluctuating). Accurate pressure control (10-100mmHg) was achieved using mass flow controllers. Human organotypic retinal cultures (HORCs) from donor eyes (<24h post mortem) were cultured in serum-free DMEM/HamF12. Increased HP was compared to simulated ischemia (oxygen glucose deprivation, OGD). Cell death and apoptosis were measured by LDH and TUNEL assays, RGC marker expression by qRT-PCR (THY-1) and RGC number by immunohistochemistry (NeuN). Activated p38 and JNK were detected by Western blot. Exposure of HORCs to constant (60mmHg) or fluctuating (10-100mmHg; 1 cycle/min) pressure for 24 or 48h caused no loss of structural integrity, LDH release, decrease in RGC marker expression (THY-1) or loss of RGCs compared with controls. In addition, there was no increase in TUNEL-positive NeuN-labelled cells at either time-point indicating no increase in apoptosis of RGCs. OGD increased apoptosis, reduced RGC marker expression and RGC number and caused elevated LDH release at 24h. p38 and JNK phosphorylation remained unchanged in HORCs exposed to fluctuating pressure (10-100mmHg; 1 cycle/min) for 15, 30, 60 and 90min durations, whereas OGD (3h) increased activation of p38 and JNK, remaining elevated for 90min post-OGD. Directly applied HP had no detectable impact on RGC survival and stress-signalling in HORCs. Simulated ischemia, however, activated stress pathways and caused RGC death. These results show that direct HP does not cause degeneration of RGCs in the ex vivo human retina.

1 January 2008 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
VTVictoria E. Tovell
Victoria E. Tovell
JSJulie Sanderson
Julie Sanderson
Purpose. Nucleotide signaling plays a role in retinal pigment epithelial (RPE) function, and receptors for nucleotides are potential therapeutic targets for various ocular diseases. The purpose of this study was to investigate the expression of P2Y receptor subtypes in native and cultured human RPE cells. methods. Intracellular Ca2+ levels were monitored using real-time fluorescence imaging in cultured human RPE cells loaded with Fura-2. Expression of P2Y receptors in native and cultured RPE cells was determined by quantitative RT-PCR and Western blot analysis. results. Adenosine triphosphate (ATP), uridine triphosphate (UTP), adenosine diphosphate (ADP), 2-methylthio ATP (2MeSATP), and uridine diphosphate (UDP) produced concentration-related increases in [Ca2+]i in cultured RPE cells. However, differences between the magnitude and shape of agonist responses were observed. ATP and UTP showed similar response characteristics, including a distinct Ca2+ influx component. ATP and UTP were equipotent (EC50, 6 μM) and maximum responses were equivalent, suggesting activation of a P2Y2 receptor. Maximal responses to ADP and 2MeSATP were equivalent with EC50s of 1 μM and 0.3 μM. The P2Y1 antagonist MRS 2179 (10 μM) inhibited these responses, confirming functional expression of P2Y1 receptors. The presence of a response to UDP suggested P2Y6 expression. There was no influx component to P2Y1- and P2Y6-mediated responses. mRNA for P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes was found in cultured RPE cells, and for P2Y1, P2Y2, P2Y4, P2Y6, and P2Y12 it was found in native RPE cells. Expression of P2Y1, P2Y2, and P2Y6 protein was found in native and cultured RPE cells. conclusions. These data define the expression profile of P2Y receptors in human RPE and show that different P2Y subtypes control distinct calcium responses in these cells.